001     285264
005     20260219163023.0
024 7 _ |a 10.1038/s41380-025-03230-7
|2 doi
024 7 _ |a pmid:41028570
|2 pmid
024 7 _ |a 1359-4184
|2 ISSN
024 7 _ |a 1476-5578
|2 ISSN
037 _ _ |a DZNE-2026-00206
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Butt, Umer Javed
|0 0000-0001-6313-5939
|b 0
245 _ _ |a Forebrain-specific loss of erythropoietin provokes compensatory upregulation of different EPO receptors.
260 _ _ |a [London]
|c 2026
|b Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1771514941_2909
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The procognitive growth factor erythropoietin (EPO) and its canonical receptor, EPOR, have long been recognized to be expressed by most cell types in the brain. Cognitive domains, improved by injections of exogenous EPO or by endogenous, hypoxia-stimulated EPO, include important forebrain functions, namely attention, working memory, drive, and executive performance. To gain mechanistic insight into the involvement of forebrain-expressed EPO, we deleted EPO in mice using as specific cre-driver Emx1. Here, we report that these mutant mice act comparably to their wildtype littermates in a comprehensive behavioral test battery. Importantly, we find that the transcripts of both EPOR and a novel, brain-expressed EPO receptor, EphB4, respond to EPO deletion with compensatory upregulation. EphB4 expression in brain and its increase upon forebrain erasure of EPOR are confirmed by in situ hybridization and immunohistochemistry. The augmented expression of both EPOR and EphB4 and their regulatory intercorrelation may explain why EmxEPO mutants show an even superior performance in the most challenging working memory task. Using the previously published single-nuclei-RNA-seq dataset, we further confirm the suggested compensatory mechanism, wherein EPO loss or reduction drives elevated EPOR expression, adding another layer to the intricate regulation of EPO signaling in hippocampal pyramidal neurons. Collectively, these data may explain the lack of behavioral and negative cognitive consequences upon forebrain-wide EPO elimination.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Erythropoietin
|0 11096-26-7
|2 NLM Chemicals
650 _ 7 |a Receptors, Erythropoietin
|2 NLM Chemicals
650 _ 7 |a Receptor, EphB4
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a Epo protein, mouse
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Erythropoietin: metabolism
|2 MeSH
650 _ 2 |a Erythropoietin: genetics
|2 MeSH
650 _ 2 |a Prosencephalon: metabolism
|2 MeSH
650 _ 2 |a Receptors, Erythropoietin: metabolism
|2 MeSH
650 _ 2 |a Receptors, Erythropoietin: genetics
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Memory, Short-Term: physiology
|2 MeSH
650 _ 2 |a Up-Regulation
|2 MeSH
650 _ 2 |a Receptor, EphB4: metabolism
|2 MeSH
650 _ 2 |a Receptor, EphB4: genetics
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Hippocampus: metabolism
|2 MeSH
650 _ 2 |a Signal Transduction
|2 MeSH
650 _ 2 |a Brain: metabolism
|2 MeSH
650 _ 2 |a Mice, Inbred C57BL
|2 MeSH
650 _ 2 |a Mice, Transgenic
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a Cognition: physiology
|2 MeSH
700 1 _ |a Çakır, Umut
|0 0000-0003-2835-3003
|b 1
700 1 _ |a Wildenburg, Anne-Fleur
|0 0009-0005-3534-3884
|b 2
700 1 _ |a Curto, Yasmina
|0 0000-0001-8087-360X
|b 3
700 1 _ |a Ye, Liu
|b 4
700 1 _ |a Bansal, Vikas
|0 P:(DE-2719)2812055
|b 5
|u dzne
700 1 _ |a Boretius, Susann
|0 0000-0003-2792-7423
|b 6
700 1 _ |a Nave, Klaus-Armin
|0 0000-0001-8724-9666
|b 7
700 1 _ |a Singh, Manvendra
|0 0000-0002-8626-5418
|b 8
700 1 _ |a Ehrenreich, Hannelore
|0 0000-0001-8371-5711
|b 9
773 _ _ |a 10.1038/s41380-025-03230-7
|g Vol. 31, no. 3, p. 1241 - 1252
|0 PERI:(DE-600)1502531-7
|n 3
|p 1241 - 1252
|t Molecular psychiatry
|v 31
|y 2026
|x 1359-4184
856 4 _ |u https://pub.dzne.de/record/285264/files/DZNE-2026-00206.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/285264/files/DZNE-2026-00206.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2812055
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-11-07
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-11-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-11-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL PSYCHIATR : 2022
|d 2025-11-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-11-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-11-07
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b MOL PSYCHIATR : 2022
|d 2025-11-07
920 1 _ |0 I:(DE-2719)1210013
|k AG Bansal
|l Biomedical Data Science
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1210013
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21